Purchase Order 75N91024P00048
Award Date 11/13/23
Potential Completion Date 11/12/24
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a $18,500 firm fixed price purchase order to Miltenyi Biotec, Inc. of Bethesda, Maryland for services to be completed by January 9, 2025. The award was made on January 10, 2024 under a non-set aside designation to support the NIH NCI's biomedical research mission. Miltenyi Biotec will provide unspecified services to the funding agency in Bethesda, Maryland through January 2025 for the...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for laboratory equipment. The place of performance is Auburn, California and the period of performance is from September 12, 2023 through October 12, 2023. The National Cancer Institute conducts and supports research aimed at discovering prevention and cures for cancer. This purchase order for laboratory...
- This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for equipment. The place of performance will be in Auburn, California, and the period of performance is from November 8, 2023 through December 26, 2023. This purchase order was awarded under the National Cancer Institute's research programs to procure equipment that will support the agency's efforts to advance cancer...
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $14,631.00 on June 18, 2020. The order procures biological and reagent materials and carries no set-aside designation. Performance occurs in Auburn, California. The ultimate completion date is July 19, 2020. Firm fixed price applies.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., for $16,626.00 on January 7, 2020, with an ultimate completion date of February 7, 2021. The order covers a maintenance agreement on firm fixed price terms. No set-aside was used. Place of performance is Auburn, California.</p>
- <p>The National Cancer Institute issued a purchase order to Miltenyi Biotec, Inc. for $16,626.00, with an award date of January 7, 2020 and ultimate completion date of January 9, 2021. The contract is a firm fixed price maintenance agreement with no set-aside designation. Place of performance is Auburn, California.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded an $18,750 purchase order to Miltenyi Biotec, Inc. for a service agreement for the MACSquant 16 flow cytometer. The place of performance will be in Rockville, Maryland. The period of performance is one year, beginning September 4, 2023 and ending September 3, 2024. Pricing is firm fixed price. This purchase order supports NCI's biomedical research mission by providing flow...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a firm-fixed-price purchase order to Miltenyi Biotec, Inc. for the purchase of a Miltenyi MACSQuant 16 Analyzer and associated accessories. The order, valued at $126,747.06, was made without the use of any set-aside designations and is intended to fulfill a requirement for the Developmental Therapeutics Branch. Miltenyi Biotec, a global biotechnology company...
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $24,980.62 on July 27, 2020, for scientific equipment with an ultimate completion date of August 31, 2020. No set-aside was used. Performance occurs in Auburn, California. The order procures specialized biotechnology equipment and reagents for cell separation, analysis, and processing technologies that support biomedical research and cell therapy development. Pricing is firm fixed price.</p>